The Efficacy of Heparin-boned Viabahn Endoprosthesis and Paclitaxel-coated Balloons for Complex Femoropopliteal Lesions

NANot yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2027

Conditions
Peripheral Arterial Disease
Interventions
DEVICE

Viabahn endoprosthesis group

Patients underwent endovascular treatment for femoropopliteal lesions. The lesion will be treated by Viabahn endoprosthesis.

DEVICE

Drug-coated balloon group

Patients underwent endovascular treatment for femoropopliteal lesions. The lesion will be treated by drug-coated balloon.

Trial Locations (1)

200127

Renji Hospital, Shanghai

All Listed Sponsors
collaborator

Chengdu University of Traditional Chinese Medicine

OTHER

collaborator

Second Affiliated Hospital of Soochow University

OTHER

collaborator

First Affiliated Hospital of Zhejiang University

OTHER

collaborator

Xuanwu Hospital, Beijing

OTHER

collaborator

Qingdao Haici Hospital

OTHER

collaborator

Liyuan Hospital of Tongji Medical College, Huazhong University of Science and Technology

OTHER

collaborator

Fudan University

OTHER

collaborator

Huashan Hospital

OTHER

collaborator

Xiamen Cardiovascular Hospital, Xiamen University

OTHER

lead

RenJi Hospital

OTHER

NCT06124755 - The Efficacy of Heparin-boned Viabahn Endoprosthesis and Paclitaxel-coated Balloons for Complex Femoropopliteal Lesions | Biotech Hunter | Biotech Hunter